NCT01484288View on ClinicalTrials.gov

Baroreflex Activation Therapy in Heart Failure

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

July 31, 2013

Study Completion Date

March 31, 2015

Conditions
Heart Failure
Interventions
DEVICE

Barostim Neo System

Baroreflex Activation Therapy using the Barostim Neo System

Trial Locations (1)

Unknown

MultiMedica, Milan

Sponsors

Lead Sponsor

CVRx, Inc.
All Listed Sponsors
lead

CVRx, Inc.

INDUSTRY

NCT01484288 - Baroreflex Activation Therapy in Heart Failure | Biotech Hunter | Biotech Hunter